
Inovio to begin late-stage Covid-19 vaccine study in second quarter
Inovio Pharmaceuticals Inc expects to start a late-stage US study of its experimental Covid-19 vaccine candidate in the second quarter of 2021, the drug developer’s chief executive officer said on ...